@article{GS2039,
author = {Víctor Manuel Vargas-Hernández and VM Vargas-Aguilar and Mario Adanm Moreno-Eutimio and Gustavo Acosta-Altamirano and JM Tovar-Rodriguez},
title = {Metabolic syndrome in breast cancer},
journal = {Gland Surgery},
volume = {2},
number = {2},
year = {2013},
keywords = {},
abstract = {Breast Cancer is a heterogeneous disease, progressive, currently, are classified according to in pattern of gene expression luminal A, luminal B, basal and HER-2neu + and Triple-negative, 75% to 80% have receptors positive hormonal and 15% to 20% are positive for hER-2neu and 10% to 20% are triple negative, with hormone receptor negative and HER2-neu and their diagnostic is made by exclusion, the Metabolic Syndrome is related to a higher incidence of these cancers where the insulin-leptin axisadiponectin are implicated in carcinogenesis.},
issn = {2227-8575}, url = {https://gs.amegroups.org/article/view/2039}
}